Compare TRXB & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRXB | EAD |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.6M | 356.3M |
| IPO Year | 2026 | N/A |
| Metric | TRXB | EAD |
|---|---|---|
| Price | $13.42 | $6.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $29.25 | N/A |
| AVG Volume (30 Days) | 86.0K | ★ 339.9K |
| Earning Date | 11-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.50 | $5.86 |
| 52 Week High | $16.56 | $6.94 |
| Indicator | TRXB | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 58.80 |
| Support Level | $13.01 | $6.07 |
| Resistance Level | $16.56 | $6.44 |
| Average True Range (ATR) | 1.22 | 0.06 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 22.66 | 96.15 |
Allspring Income Opportunities Fund is a diversified closed-end management investment company. The Fund seeks a high level of current income. Capital appreciation is a secondary objective. The fund has single operating segment.